Vaccines: Viral Vector, Recombinant Protein, Conjugate, VLP
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
701
NCT00466765
Breast Reconstruction and Augmentation With Brava Enhanced Autologous Fat Micro Grafting
Phase: N/A
Role: Lead Sponsor
Start: Jan 31, 2010
Completion: Apr 30, 2015
NCT05492123
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
Phase: Phase 2
Role: Collaborator
Start: Aug 30, 2022
Completion: Mar 31, 2028
Loading map...